Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular - Growth
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 13.13%
Fund Details
NAV 21.0563
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount 100.0
Fund Age(Year) 5.32
Fund Size 166.84
Fund Performance
1 Month 1.74%
3 Month 1.11%
6 Month 6.85%
1 Year 13.13%
3 Year 20.93%
5 Year 13.71%
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.12% Ret 1Y 7.08% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.06%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Bhavesh Jain
Education Mr. Jain is a MMS (Finance) from Mumbai University.
Experience Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Amit Vora
Education Mr. Vora has done B.Com from University of Mumbai
Experience Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk%
AMC and Fund details
Rank (total sets) 1
Date of Incorporation 2020-10-26
Total AUM 2026-01-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Know This Fund
As on 19 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (99.82%) Market Cap Mid Cap 39.48 Large Cap 24.74 Small Cap 35.6 Top Sectors Healthcare 99.82 Top Holding Novartis AG 2.13 Torrent Pharmaceuticals 3.34 Fortis Healthcare 2.98 AbbVie Inc 2.96 Vertex Pharmaceuticals Inc. (USA) 0.91 Glenmark Pharmaceuticals 2.23 Laurus Labs 2.41 Medtronic 0.99 Zydus Lifesciences 1.27 Narayana Hrudayalaya 0.9 Johnson & Johnson 4.12 Lupin 3.85 Alkem Laboratories 1.93 Biocon 1.4 Amgen Inc. (USA) 1.38 Agilent Technologies Inc 0.29 Ipca Laboratories 1.46 Syngene International 0.61 Divi's Laboratories 5.15 Global Health 0.61 Dr. Reddy's Laboratories 4.71 Stryker Corp 0.96 Iqvia Holdings 0.3 Intuitive Surgical Inc. (USA) 1.36 Gland Pharma 0.98 Illumina Inc. (USA) 0.17 Mankind Pharma 1.87 Abbott Laboratories 1.43 Aster DM Healthcare 0.92 Aurobindo Pharma 2.25 Apollo Hospitals Enterprise 5.35 Regeneron Pharmaceuticals Inc 0.58 Becton Dickinson And Co 0.44 Thermo Fisher Scientific Inc 1.64 Ajanta Pharma 0.87 Glaxosmithkline Pharma 0.72 Gilead Sciences Inc. (USA) 1.32 Merck & Co Inc (US) 2.07 Eli Lilly 6.27 Sun Pharmaceutical Industries 10.9 Piramal Pharma 0.66 Max Healthcare Institute 5.3 Cipla 5.33 Danaher Corporation 1.06 Novo Nordisk A/S - ADR 1.44
Debt & Others (0.18000000000000002%) Sector Allocation Net Payables -0.09 Cash 0 CBLO 0.27 Debt Credit Ratings Debt Category Others 0.18
Take Your Next Step
